Mohamed, International Islamic University Malaysia, Malaysia Reviewed by Subodh Kumar, Texas Tech University Health Sciences Center, United States
The primary outcome was 30-day readmission, and secondary outcomes were documented dehiscence, infection, hematoma, and bleeding within 180 days after surgery
Common transition side effects When switching from tirzepatide to semaglutide, some side effects may reappear, especially during the start of medication or during dose escalation
NAD declines with age and is critical for energy production and DNA repair
[7] Treatment [edit] Identification of patients presymptomatically via newborn screening has allowed early intervention and treatment
Ann Rheum Dis (2013) 72(3):33744